Login

Arun Jain, Chairman and CEO of Polaris Financial Technology Ltd., shares his views on ... 00:10:00

Share On Facebook Share On Twitter

Arun Jain, Chairman and CEO of Polaris Financial Technology Ltd

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Back to the Future: Building Impactful Companies|Andrew Schoen,Partner,New Enterprise Associates (NEA)
00:10:00
Evaluating the Competitive Threat of Fintechs to Emerging Market Banks: Insights from T. Rowe Price
00:10:00
Mehvish Ayub of State Street Global Advisors provides sector allocations during the recovery while outlining State Street's house view.|Olivia is a Senior Managing Director of State Street Global Advisors
00:10:00
French energy company discusses gas recovery projects in France and abroad, emphasizing carbon footprint reduction | Julien Moulin, CEO, La Francaise de l Energie SA.
00:00:00
An overview of Cocrystal’s core technology and applications in development - JAMES J. MARTIN Co-Chief Executive Officer and Chief Financial Officer, Cocrystal Pharma Inc
00:10:00
Understanding In-Kind Support and Maintenance (ISM) and Its Impact on SSI Benefits | Mike Walther, President , Oak Wealth Advisors LLC.
00:10:00
We help to building tomorrows companies today|Akshay Bhushan,Venture Partner,Lightspeed Venture Partners
00:10:00
James Dickson, CEO of Vianet Group plc (LON), presents at the Virtual Growth & Innovation Forum, highlighting the company's diverse portfolio.|James Dickson, CEO of Vianet Group plc
00:00:00
Talk about the company's joint venture to expand Positron Emission Tomography (PET)S - teven J. Mento, CEO, Conatus Pharmaceuticals
00:10:00
Navigating Hedge Fund Startups: Insights on ADV Forms and Compliance | Turn Key Hedge Funds - Launch Consultant
00:10:00
A Quantitative Edge in China A-Shares and Global Access via Hong Kong|Bo Huang,President,Jasper Capital
00:10:00
invest $300K-$500K at the earliest stages in DTC, AdTech, & NextGen Commerce companies|Andrew Gluck,General Partner,irrvrntVC

© 2017 - Neuhu+